false 0001568651 0001568651 2024-06-06 2024-06-06

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): June 6, 2024

 

 

Oscar Health, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

 

 

Delaware   001-40154   46-1315570
(State or Other Jurisdiction
of Incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

 

75 Varick Street, 5th Floor
New York, New York 10013
(Address of Principal Executive Offices) (Zip Code)

(646) 403-3677

(Registrant’s telephone number, including area code)

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange

on which registered

Class A Common Stock, $0.00001 par value per share   OSCR   New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 


Item 5.07.

Submission of Matters to a Vote of Security Holders.

On June 6, 2024, Oscar Health, Inc. (the “Company”) held its 2024 Annual Meeting of Stockholders (the “Annual Meeting”). As of the close of business on April 10, 2024 (the “Record Date”), there were 201,466,384 shares of Class A common stock outstanding, each share being entitled to one vote, and 35,514,201 shares of Class B common stock outstanding, each share of Class B common stock being entitled to 20 votes (the Class A common stock and Class B common stock, collectively, the “Common Stock”). Accordingly, as of the Record Date, there were 201,466,384 Class A common stock votes and 710,284,020 Class B common stock votes, respectively, available to be cast, for a total of 911,750,404 votes available to be cast. At the Annual Meeting, the holders of 862,222,532 votes of the Common Stock were represented in person or by proxy, constituting a quorum. The following are the voting results for the proposals considered and voted upon at the meeting, each of which were described in the Company’s Definitive Proxy Statement filed with the Securities and Exchange Commission on April 25, 2024.

Item 1 - Election of ten directors to hold office until the Annual Meeting of Stockholders to be held in 2025 and until each such director’s respective successor is elected and qualified or until each such director’s earlier death, resignation or removal.

 

Nominee   Votes FOR   Votes
WITHHELD
  Broker Non-Votes

Mark T. Bertolini

  840,385,804   995,581   20,841,147

Jeffery H. Boyd

  838,844,381   2,537,004   20,841,147

William Gassen III

  839,353,787   2,027,598   20,841,147

Joshua Kushner

  795,914,488   45,466,897   20,841,147

Laura Lang

  828,871,267   12,510,118   20,841,147

David Plouffe

  839,076,028   2,305,357   20,841,147

Elbert O. Robinson, Jr.

  840,232,216   1,149,169   20,841,147

Siddhartha Sankaran

  835,849,067   5,532,318   20,841,147

Mario Schlosser

  836,093,799   5,287,586   20,841,147

Vanessa A. Wittman

  840,303,047   1,078,338   20,841,147

Item 2 - Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024.

 

Votes FOR   Votes AGAINST   Votes ABSTAINED   Broker Non-Votes

861,722,397

  440,912   59,223   0

Item 3 - Approval, on an advisory (non-binding) basis, of the compensation of the Company’s named executive officers.

 

Votes FOR   Votes AGAINST   Votes ABSTAINED   Broker Non-Votes

790,922,167

  50,399,416   59,802   20,841,147

Based on the foregoing votes, the ten director nominees were elected, and Items 2 and 3 were approved.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    Oscar Health, Inc.
Date: June 11, 2024     By:  

/s/ Ranmali Bopitiya

      Ranmali Bopitiya
      Chief Legal Officer
v3.24.1.1.u2
Document and Entity Information
Jun. 06, 2024
Cover [Abstract]  
Amendment Flag false
Entity Central Index Key 0001568651
Document Type 8-K
Document Period End Date Jun. 06, 2024
Entity Registrant Name Oscar Health, Inc.
Entity Incorporation State Country Code DE
Entity File Number 001-40154
Entity Tax Identification Number 46-1315570
Entity Address, Address Line One 75 Varick Street
Entity Address, Address Line Two 5th Floor
Entity Address, City or Town New York
Entity Address, State or Province NY
Entity Address, Postal Zip Code 10013
City Area Code (646)
Local Phone Number 403-3677
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Class A Common Stock, $0.00001 par value per share
Trading Symbol OSCR
Security Exchange Name NYSE
Entity Emerging Growth Company false

Grafico Azioni Oscar Health (NYSE:OSCR)
Storico
Da Nov 2024 a Dic 2024 Clicca qui per i Grafici di Oscar Health
Grafico Azioni Oscar Health (NYSE:OSCR)
Storico
Da Dic 2023 a Dic 2024 Clicca qui per i Grafici di Oscar Health